Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tessandra Stewart

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
CNS Neuroscience & Therapeutics|August 11, 2023
GV-971 attenuates α-Synuclein aggregation and related pathologyZhenwei Yu, Ying Yang, Robin Barry Chan, et al.
Neurobiology of Disease|April 30, 2018
Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot studyHua Wang, Anzari Atik, Tessandra Stewart, et al.
Journal of Proteome Research|May 24, 2014
Targeted discovery and validation of plasma biomarkers of Parkinson's diseaseCatherine Pan, Yong Zhou, Romel Dator, et al.
Acta Neuropathologica Communications|March 9, 2021
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's diseaseXiaodan Liu, Qilong Wang, Ying Yang, et al.
Brain : a Journal of Neurology|September 17, 2009
Functional definition of seizure provides new insight into post-traumatic epileptogenesisRaimondo D'Ambrosio, Shahin Hakimian, Tessandra Stewart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2023
Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's DiseaseYing Yang, Tessandra Stewart, Can Zhang, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on BiomarkersTessandra Stewart, Min Shi, Aanchal Mehrotra, et al.
Proteomics. Clinical Applications|March 21, 2017
An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionLi Yang, Tessandra Stewart, Min Shi, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive ImpairmentHua Wang, Tessandra Stewart, Jon B Toledo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2022
Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's diseaseChen Tian, Tessandra Stewart, Zhen Hong, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
CNS Neuroscience & Therapeutics|August 11, 2023
GV-971 attenuates α-Synuclein aggregation and related pathologyZhenwei Yu, Ying Yang, Robin Barry Chan, et al.
Neurobiology of Disease|April 30, 2018
Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot studyHua Wang, Anzari Atik, Tessandra Stewart, et al.
Journal of Proteome Research|May 24, 2014
Targeted discovery and validation of plasma biomarkers of Parkinson's diseaseCatherine Pan, Yong Zhou, Romel Dator, et al.
Acta Neuropathologica Communications|March 9, 2021
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's diseaseXiaodan Liu, Qilong Wang, Ying Yang, et al.
Brain : a Journal of Neurology|September 17, 2009
Functional definition of seizure provides new insight into post-traumatic epileptogenesisRaimondo D'Ambrosio, Shahin Hakimian, Tessandra Stewart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2023
Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's DiseaseYing Yang, Tessandra Stewart, Can Zhang, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on BiomarkersTessandra Stewart, Min Shi, Aanchal Mehrotra, et al.
Proteomics. Clinical Applications|March 21, 2017
An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionLi Yang, Tessandra Stewart, Min Shi, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive ImpairmentHua Wang, Tessandra Stewart, Jon B Toledo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2022
Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's diseaseChen Tian, Tessandra Stewart, Zhen Hong, et al.
Pageof 4